Results 81 to 90 of about 1,205 (167)

Establishing the Profile of Eye Diseases at Nkhatabay District Hospital, Malawi: A Retrospective Study

Health Science Reports, Volume 9, Issue 3, March 2026.
ABSTRACT Background The distribution of eye diseases differs depending on the geographical and socioeconomic context. Aim Therefore, this study analysed the pattern of eye conditions and diseases among patients at Nkhatabay District Hospital in Malawi. Methods This was a quantitative retrospective study conducted by extracting data from the outpatient ...
Mercy Gaveta, Thokozani Mzumara, Jalif Chitseko, Bright Vandyke Okyere   +3 more
wiley   +1 more source

ANALYSIS OF THE EFFECTIVENESS OF ANTIVIRAL TREATMENT OF PATI ENTS WITH CHRONIC HEPATITIS C ACCORDING TO THE SCHEME OBV/PTV /R+DSV±RBV DEPENDING ON THE PRESENCE OF COMORBID RENAL FAILU RE

, 2022
Using of medicine with a direct mechanism of action has ex panded the group of patients who can receive treatment for chronic hepatitis C(CHC). Patients without concomitant renal pathology and with comorbid ren al insufficiency (RІ) stage V, who receive hemodialysis (HD) may receive a 3Dregimen for the treatment of CHC [1,2]
openaire   +2 more sources

OBV met flexibele renteclausule kwalificeert voor 'ventieltechniek' [PDF]

, 2004
Contains fulltext : 64951.pdf (Publisher’s version ) (Open Access)
openaire   +1 more source

Efficacy and safety of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin in treatment of patients with chronic hepatitis C in the Republic of Srpska: A real-life study [PDF]

Scripta Medica, 2019
Background: The purpose of this study was to assess the antiviral efficacy and safety of the direct-acting antivirals (DAAs) in therapy of chronic hepatitis C virus (HCV) infection.
Verhaz Antonija, Kezić Zdravka, Stojiljković Miloš P., Škrbić Ranko   +3 more
doaj  

Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir ± Ribavirin for HCV in Brazilian Adults with Advanced Fibrosis

Annals of Hepatology, 2018
Introduction and aim. Approximately 650,000 people in Brazil have chronic hepatitis C virus (HCV) infection. We evaluated the safety and efficacy of ombitasvir (OBV)/paritaprevir (PTV)/ritonavir (r) plus dasabuvir (DSV) with/without ribavirin (RBV) in an
Mario G. Pessoa, José V. Ramalho-Madruga, Katia Alves, Estevão P. Nunes, Hugo Cheinquer, Carlos E. Brandão-Mello, Maria C. Mendes-Correa, Maria L. Ferraz, Paulo R.A. Ferreira, Mário R. Álvares-da-Silva, Henrique S. Coelho, Evaldo S. Affonso-de-Araújo, Juvencio Furtado, Raymundo Parana, Giovanni Silva, Sara A. Lari, Li Liu, Rakesh Tripathi, Tami Pilot-Matias, Daniel E. Cohen, Nancy S. Shulman, Ana Martinelli   +21 more
doaj   +1 more source

On OBV Methods

, 1979
info:eu-repo/semantics ...
openaire   +1 more source

Efficacy and Safety of Ombitasvir, Paritaprevir and Ritonavir plus Ribavirin in Hepatitis C Genotype-4 Patients on Hemodialysis

Archives of Pharmaceutical Sciences Ain Shams University, 2020
Background: The ongoing standard treatment for patients with chronic hepatitis C virus (HCV) is a mixture of direct-acting antiviral agents (DAAs). Aim of work: the aim of this study is to analyse the efficacy and safety of oral interferon-free regimen ...
Mai Abdelmen , Nagwa Ali Sabri, Sara Shahin, Ashraf Ahmed Aboubakr   +3 more
doaj  

De `obv-plus' als het beste van twee erfrechtelijke werelden

, 2007
Contains fulltext : 38018.pdf (Publisher’s version ) (Open Access)
openaire   +2 more sources

De obv-plus-rage. Ook het 'beste' testament van twee successierechtelijke werelden: vóór en na 'De Jager'? [PDF]

, 2008
3 p.
openaire   +1 more source

Decoding defensive performance: a machine learning approach to football player valuation

Journal of Big Data
Analyzing defensive actions, which have traditionally received less attention than offensive metrics, is a significant challenge in football analytics.
Michał Zarȩba, Tomasz Piłka, Tomasz Górecki, Bartłomiej Grzelak, Krzysztof Dyczkowski   +4 more
doaj   +1 more source